Latest Us Government Funding News

Red Mountain Mining is set to list on the US OTCQB exchange, offering US investors direct access to its shares while expanding its portfolio of critical antimony assets in key US mining districts.

Nimy Resources has completed a major drilling campaign confirming high-grade gallium mineralisation and made significant copper-nickel discoveries at its Mons Project in Western Australia, while forging strategic ties with US partners to advance its critical minerals ambitions.

Pioneer Lithium has sharpened its focus on North American critical minerals, advancing uranium, antimony, and tungsten projects while securing $750,000 in fresh capital to fund exploration and working capital.

Island Pharmaceuticals has completed its acquisition of the broad-spectrum antiviral Galidesivir and is progressing regulatory discussions with the FDA to fast-track approval using the Animal Rule, backed by compelling preclinical data.

Resolution Minerals is fast-tracking its downstream antimony strategy in Idaho, aiming to become a key US supplier while preparing for a Nasdaq listing with Tribeca Capital's support.

Victory Metals secures $11.5 million through a strategic placement to accelerate drilling and development at its North Stanmore heavy rare earth project, reinforcing its position as Australia’s leading rare earths explorer.

Codan Limited reported a robust FY25 with 22% revenue growth to $674.2 million and a 27% jump in net profit, driven by organic expansion and strategic acquisitions. The company’s communications and metal detection segments both posted solid gains, setting a confident tone for FY26.

Carnegie Clean Energy launches a $3 million Share Purchase Plan to fuel commercialisation of its wave and MoorPower technologies, capitalising on growing global momentum in ocean energy.

Nimy Resources has appointed NYSE-listed M2i Global to spearhead its US government funding strategy, targeting key grants and loans to advance its gallium projects. This partnership aligns Nimy with critical supply chain initiatives in the United States.

Island Pharmaceuticals reported promising Phase 2a/b trial results for its dengue drug ISLA-101 and secured a strategic acquisition of the broad-spectrum antiviral Galidesivir, bolstering its pipeline and balance sheet.

Silex Systems reports steady progress on its TRL-6 uranium enrichment demonstration, targeting completion by end-2025, while securing initial US government funding to support commercialisation efforts.

American West Metals has unveiled a positive Preliminary Economic Analysis for its Storm Copper Project in Canada, outlining a low-cost, 10-year production plan with strong financial returns. The company also secured a strategic funding and offtake partnership with Ocean Partners, while advancing its critical minerals projects in the US.